Cargando…

Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients

BACKGROUND: Immunotherapeutic approaches, such as dendritic cell (DC) vaccination, have emerged as promising strategies in the treatment of glioblastoma. Despite their promise, however, the absence of objective biomarkers and/or immunological monitoring techniques to assess the clinical efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Everson, Richard G, Jin, Richard M, Wang, Xiaoyan, Safaee, Michael, Scharnweber, Rudi, Lisiero, Dominique N, Soto, Horacio, Liau, Linda M, Prins, Robert M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039989/ https://www.ncbi.nlm.nih.gov/pubmed/24883189 http://dx.doi.org/10.1186/2051-1426-2-10

Ejemplares similares

The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells
por: Lisiero, Dominique N, et al.
Publicado: (2014)

Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients
por: Fong, Brendan, et al.
Publicado: (2012)

Correction: Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients
por: Fong, Brendan, et al.
Publicado: (2012)

Correction: Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients
por: Fong, Brendan, et al.
Publicado: (2012)

Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response
por: Antonios, Joseph, et al.
Publicado: (2015)

Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients
por: Everson, Richard G., et al.
Publicado: (2023)

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma
por: Lee, Alexander H., et al.
Publicado: (2021)

Reproducibility of serum cytokines in an elderly population
por: Guo, Jing, et al.
Publicado: (2020)

Proportional Upregulation of CD97 Isoforms in Glioblastoma and Glioblastoma-Derived Brain Tumor Initiating Cells
por: Safaee, Michael, et al.
Publicado: (2015)

Overexpression of CD97 Confers an Invasive Phenotype in Glioblastoma Cells and Is Associated with Decreased Survival of Glioblastoma Patients
por: Safaee, Michael, et al.
Publicado: (2013)

Harnessing T-Cell Immunity to Target Brain Tumors
por: Walker, Paul R., et al.
Publicado: (2008)

Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma
por: Patel, Kunal S., et al.
Publicado: (2020)

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
por: Gardam, Bryan, et al.
Publicado: (2023)

Essential Gene Pathways for Glioblastoma Stem Cells: Clinical Implications for Prevention of Tumor Recurrence
por: Yamada, Kazunari, et al.
Publicado: (2011)

Regulation of Porcine Plasmacytoid Dendritic Cells by Cytokines
por: Lannes, Nils, et al.
Publicado: (2013)

NSAIDs affect dendritic cell cytokine production
por: Raaijmakers, Tonke K., et al.
Publicado: (2022)

IMMU-04. TARGETING ALTERNATIVE SPLICING VARIANTS TO STIMULATE ANTI-TUMOR IMMUNITY IN A NOVEL SYNGENEIC MOUSE MODEL OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT
por: Owens, Geoffrey, et al.
Publicado: (2023)

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme
por: Yang, Liu, et al.
Publicado: (2015)

Near-Complete Remission of Glioblastoma in a Patient Treated with an Allogenic Dendritic Cell-Based Vaccine: The Role of Tumor-Specific CD4+T-Cell Cytokine Secretion Pattern in Predicting Response and Recurrence
por: Pinho, Mariana P., et al.
Publicado: (2022)

Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity
por: Jensen, Simon S, et al.
Publicado: (2010)

Combinatorial Cytokine Code Generates Anti-Viral State in Dendritic Cells
por: Hartmann, Boris M., et al.
Publicado: (2014)

Adverse event detection by medical record review is reproducible, but the assessment of their preventability is not
por: Klein, Dorthe O., et al.
Publicado: (2018)

Dermal IRF4+ dendritic cells and monocytes license CD4+ T helper cells to distinct cytokine profiles
por: Hilligan, Kerry L., et al.
Publicado: (2020)

Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines
por: Safaee, Sahar, et al.
Publicado: (2021)

CD36 Contributes to Malaria Parasite-Induced Pro-Inflammatory Cytokine Production and NK and T Cell Activation by Dendritic Cells
por: Gowda, Nagaraj M., et al.
Publicado: (2013)

Yeast Modulation of Human Dendritic Cell Cytokine Secretion: An In Vitro Study
por: Smith, Ida M., et al.
Publicado: (2014)

Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme
por: Jan, Chia-Ing, et al.
Publicado: (2018)

Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
por: Datsi, Angeliki, et al.
Publicado: (2021)

HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs
por: Huynh, Mailee, et al.
Publicado: (2022)

Overexpression of Calcium-Permeable Glutamate Receptors in Glioblastoma Derived Brain Tumor Initiating Cells
por: Oh, Michael C., et al.
Publicado: (2012)

Reproducibility and cell biology
por: Yamada, Kenneth M., et al.
Publicado: (2015)

Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone
por: Kappadakunnel, Melanie, et al.
Publicado: (2009)

Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis
por: Wenink, Mark H, et al.
Publicado: (2011)

Environmental Alkylphenols Modulate Cytokine Expression in Plasmacytoid Dendritic Cells
por: Hung, Chih-Hsing, et al.
Publicado: (2013)

TMPRSS2 Impacts Cytokine Expression in Murine Dendritic Cells
por: Gunne, Sandra, et al.
Publicado: (2023)

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
por: Liau, Linda M., et al.
Publicado: (2018)

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
por: Garzon-Muvdi, Tomas, et al.
Publicado: (2018)

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
por: Liu, Qinghai, et al.
Publicado: (2009)

Dendritic Cell Derived Cytokines in Human Natural Killer Cell Differentiation and Activation
por: Chijioke, Obinna, et al.
Publicado: (2013)

Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia
por: Saulep-Easton, Damien, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8e0o0go2tksgf3oe34o6tjdunc